Company Introduction
Shanghai Yaxin Biotechnology Co., Ltd. is a biotech company founded in 2008 that focuses on the research and the production of recombinant proteins. YaxinBio already offers three types of Animal Origin Free recombinant proteins: recombinant Carboxypeptidase B, recombinant Trypsin and recombinant Lipase A. Both recombinant Carboxypeptidase B and recombinant Trypsin have no trace of other enzyme activities or enzyme inhibitors. Our Animal Origin Free products have been successfully used in the production process of recombinant insulin by several companies. Recombinant Trypsin can also be used in the process of cell culture. Shanghai Yaxin Biotechnology Co., Ltd., located in Shanghai Juke Biotech Park, is ISO 9001 registered company since 2009.
Order Credit Report
Company Basic Information
- - Company Name
Shanghai Yaxin Biotechnology Co., Ltd.
- - Location
Shanghai
- - Business Type
Manufacturer
- - Year Established
2008
- - Employees Total
51 - 100
- - Annual Revenue
USD 100,000 - 500,000
- - Website
-
- - EC21 Storefrontyxswjs.en.ec21.com
-
- Selling Categories
Chemicals > Chemical Reagents
-
- Buying Categories
Chemicals > Chemical Reagents
- - KeywordEnzyme, Trypsin, Carboxypeptidase, Lipase, Protein A, Recombinant, Recombinant Carboxypeptidase, Recombinant Lipase, Enterokinase, ADK
Contact Information
- - Address
No.466 Yin Du Road, Xuhui, Shanghai, China Shanghai, Shanghai
- - Country/Region
China
- - Phone
86 - 21 - 54336592
- - Fax
86 - 021 - 54336593
- - Contact Zhao Zhi
EC21 Membership Information
- - Membership Class Free Member
- - Membership Year 16 years
- - EC21 Registered Date Jun 09. 2010
- - Authentication Unverified
- - EC21 Registered IP
180.173.60.***
This is
Shanghai Yaxin Biotechnology Co., Ltd.‘s IP address when
Shanghai Yaxin Biotechnology Co., Ltd. joined EC21.com.
- Geolocation based on IP address:
China
Please use above information to identify fraud company with rough assumption. It has 99.8% accuracy on a country level.
EC21 is always do our best to become the clean B2B market.